Roche and Wellthy Diagnostics presented at the recent Scientific Sessions of the American Diabetes Association in San Francisco, compelling data of improved diabetes care outcomes in a South Asian population when patients followed a prescribed plan of medication and lifestyle modification in conjunction with a combination therapy of self-monitoring blood glucose device and a clinically validated digital therapeutic (DTx).
Menu